Epoxymicheliolide

Epoxymicheliolide
Product Name Epoxymicheliolide
CAS No.: 1343403-10-0
Catalog No.: CFN91038
Molecular Formula: C15H20O4
Molecular Weight: 264.3 g/mol
Purity: >=98%
Type of Compound: Sesquiterpenoids
Physical Desc.: Powder
Targets: NF‑κB | COX‑2
Source: The roots of Inula helenium L.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price: $198/10mg
Epoxymicheliolide, a novelguaiane-type sesquiterpene lactone, inhibits NF‑κB/COX‑2 signaling pathways by targeting leucine 281 and leucine 25 in IKKβ in renal cell carcinoma, it may be a novel anticancer agent in the treatment of renal cell carcinoma.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Revista Brasileira de Farmacognosia2024, 34:1091-1100.
  • J Biochem Mol Toxicol.2022, e23211.
  • Preprints2022, 202211.0388.v1.
  • The Thai Journal of Pharmaceutical Sciences2023, 47(3):3.
  • Curr Res Virol Sci.2022, 3:100019.
  • J Lipid Res.2024, 65(10):100640.
  • J Int Med Res.2021, 49(7):3000605211032849.
  • Evid Based Complement Alternat Med.2019, 2019:2135351
  • J Korean Med Ophthalmol Otolaryngol Dermatol2023, 36(1):21-39.
  • Front Plant Sci.2022, 13:982771.
  • Petunidin-3-O-galactoside chloride

    Catalog No: CFN92042
    CAS No: 28500-02-9
    Price: $318/5mg
    Licoricesaponin H2

    Catalog No: CFN95173
    CAS No: 118441-85-3
    Price: $368/20mg
    Harzianic acid

    Catalog No: CFN00118
    CAS No: 157148-06-6
    Price: Inquiry(manager@chemfaces.com)
    Resibufogenin

    Catalog No: CFN98543
    CAS No: 465-39-4
    Price: $118/20mg
    Apigenin 5-O-beta-D-glucopyranoside

    Catalog No: CFN98352
    CAS No: 28757-27-9
    Price: $318/10mg
     International Journal of Oncology,2018,53(3).
    Epoxymicheliolide, a novelguaiane-type sesquiterpene lactone, inhibits NF‑κB/COX‑2 signaling pathways by targeting leucine 281 and leucine 25 in IKKβ in renal cell carcinoma[Reference: WebLink]
    Parthenolide (PTL) is a sesquiterpene lactone compound obtained from Tanacetum parthenium (feverfew) and inhibits the activation of nuclear factor (NF)-κB. Epoxymicheliolide (EMCL) is a compound which is structurally related to PTL; however, EMCL is more stable under acidic and alkaline conditions. As a biologically active molecule, the detailed mechanism by which EMCL inhibits tumor activity remains to be elucidated.
    METHODS AND RESULTS:
    The present study evaluated the effect of EMCL on renal cell carcinoma (RCC) cells and identified the underlying mechanisms. It was found that treatment with EMCL significantly inhibited the proliferation of RCC cells in vitro and increased the induction of apoptosis by activating the mitochondria- and caspase-dependent pathway. Simultaneously, EMCL suppressed cell invasion and metastasis by inhibiting epithelial-mesenchymal transition, as observed in a microfluidic chip assay. Furthermore, using immunofluorescence analysis, an electrophoretic mobility shift assay and a dual-luciferase reporter assay, it was shown that treatment with EMCL significantly suppressed the expression of cyclooxygenase‑2 by inhibiting the translocation of NF‑κB p50/p65 and the activity of NF‑κB.
    CONCLUSIONS:
    Collectively, the results indicated that EMCL suppressed tumor growth by inhibiting the activation of NF‑κB and suggested that EMCL may be a novel anticancer agent in the treatment of RCC.
    2'-Rhamnoechinacoside

    Catalog No: CFN95035
    CAS No: 1422390-59-7
    Price: $368/10mg
    1-Methyl-2,8-dihydroxy-3-carboxy-9,10-anthraquinone

    Catalog No: CFN95101
    CAS No: 1401414-53-6
    Price: $338/5mg
    Silybin A

    Catalog No: CFN95149
    CAS No: 22888-70-6
    Price: $318/20mg
    Polygalasaponin XXXV

    Catalog No: CFN95176
    CAS No: 184479-28-5
    Price: $463/5mg
    [(1(10)E,2R,4R)]-2-Methoxy-8,12-epoxygemacra-1(10),7,11-trien-6-one

    Catalog No: CFN95198
    CAS No: 75412-95-2
    Price: $318/10mg
    2-Methoxyfuranoguaia-9-ene-8-one

    Catalog No: CFN95220
    CAS No: 88010-62-2
    Price: $318/10mg
    Solafuranone

    Catalog No: CFN95312
    CAS No: 367965-50-2
    Price: $318/5mg
    New compound 8

    Catalog No: CFN95341
    CAS No: N/A
    Price: $318/5mg
    3-Hydroxymollugin

    Catalog No: CFN95424
    CAS No: 154706-45-3
    Price: $368/5mg
    (Z)-Ferulic acid 4-O-beta-D-glucoside

    Catalog No: CFN95546
    CAS No: 94942-20-8
    Price: $168/20mg